Ezetimibe co-administered with a statin is contraindicated during pregnancy and lactation (see Contraindications), refer to the monograph for that particular statin.
Pregnancy: Ezetimibe should be given to pregnant women only if clearly necessary. Ezetimibein monotherapy have shown no evidence of direct or indirect harmful effects on pregnancy, embryofoetal development, birth or postnatal development.
Lactation: Ezetimibe should not be used during lactation. It is not known if ezetimibe is secreted into human breast milk.